New immune cell therapy tested for kids with tough leukemia
Disease control
Not yet recruiting
This early-stage trial is testing a new type of treatment called CART123 for children and young adults whose acute myeloid leukemia (AML) has come back or hasn't responded to other therapies. The study will see if these specially engineered immune cells are safe and work better w…
Phase: PHASE1 • Sponsor: Stephan Grupp MD PhD • Aim: Disease control
Last updated Mar 23, 2026 15:17 UTC